Injectable drugs are injected by various routes of administration, such as intravenous, intramuscular, sub-cutaneous, etc. to treat a number of diseases such as cardiovascular, respiratory, cancer, etc. Healthcare professionals can inject many medications into different parts of the body. They will decide the most appropriate route of access depending on the situation.
Market Dynamics
Rapid therapeutic effect of injectable drugs is leads to increase the demand for the injectable products. Thus, key market players are engaged in enhancing manufacturing facilities of pharmaceutical products and strengthening their market position in Africa. This, in turn, is expected to drive the market growth. For instance, the African Union Commission (AUC) and the United Nations Industrial Development Organization (UNIDO) developed a business plan to accelerate the implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA), with funding from the German government. Moreover, injectable drugs offer potential benefits to patients with human immunodeficiency virus (HIV) on anti-retroviral therapy (ART) in low-income settings in sub-Saharan Africa. This in turn to increase usage of injectable drugs to treat HIV patients and thereby drive the growth of market in Africa. Furthermore, surge in presence of branded formulations is anticipated to drive the growth of market. For instance, branded formulations for bupivacaine injection such as Macaine HCL, (0.5% for spinal injection), Macaine HCL, (0.5% for injection with Dextrose), and Macaine HCL, (0.5% injection) are available in African countries, majorly in South Africa. Major manufacturers in Africa such as Pharma-Q Holdings (Pty) Ltd. and Adcock Ingram Limited offer bupivacaine injection in South Africa and other countries in Africa. In addition, manufactures operating in the market are appointing a distributors and thus increases the number of suppliers. This in turn to propel the growth of market. For instance, online distributors/pharmacies such as Seif Pharmacy in Egypt offers Isoptin (5 mg / 2ml) in the country. Pharmaceutical suppliers such as Pharmachemie (Pty) Ltd. and Sanofi-Aventis South Africa (Pty) Ltd. supply Fludarabine brands to the Department of Health, South Africa
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients